Antibodies in recovered victums’ blood may hold key to COVID-19 cure
In the race to develop treatments for the coronavirus, two California biotech companies are teaming up to collect blood samples from people who have
recovered from COVID-19 — with the hope that antibodies produced by their immune system after being infected can provide the key to developing a drug or vaccine.
Phlebotomist Teams Assisting Researchers in Select Cities
Transcript:
Trace Gallagher:
Well, phlebotomists just may be the unsung heroes in the fight against COVID-19. Teams of licensed phlebotomists in select cities are suiting up in protective gear and masks and heading into homes of former coronavirus patients.
Biotech company needs your help with advance research.
Vir Biotechnology is looking for patients in San Diego and Los Angeles counties who have recovered from COVID-19 to donate blood to help
the company find better ways to diagnose and treat the infection.
